Yvonne Zimmermann Selected Research

Antibodies

2/2015

Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yvonne Zimmermann Research Topics

Disease

7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2016 - 02/2006
2	Lymphoma (Lymphomas) 02/2016 - 01/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Disease Progression 02/2010
1	Neoplasms (Cancer) 11/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2005
1	Microsatellite Instability 05/2005

Drug/Important Bio-Agent (IBA)

4	Bortezomib (Velcade)FDA Link 01/2015 - 03/2009
2	temsirolimus FDA Link 02/2016 - 01/2015
2	Proteasome InhibitorsIBA 06/2012 - 03/2009
2	Proteins (Proteins, Gene)FDA Link 11/2009 - 03/2009
1	Bendamustine Hydrochloride FDA Link 02/2016
1	obinutuzumabIBA 02/2015
1	AntibodiesIBA 02/2015
1	Rituximab (Mabthera)FDA Link 02/2015
1	ibrutinibIBA 01/2015
1	idelalisibIBA 01/2015
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2015
1	MTOR InhibitorsIBA 01/2015
1	ATP dependent 26S protease (26S proteasome)IBA 06/2012
1	RNA (Ribonucleic Acid)IBA 02/2010
1	enzastaurinIBA 02/2010
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2009
1	Cyclin D1IBA 11/2009
1	3' Untranslated Regions (3' UTR)IBA 11/2009
1	MicroRNAs (MicroRNA)IBA 11/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2009
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 02/2006
1	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2006

Therapy/Procedure

1	Therapeutics 02/2010
1	Drug Therapy (Chemotherapy) 05/2005